Ribes Sandra, Ebert Sandra, Czesnik Dirk, Regen Tommy, Zeug Andre, Bukowski Stephanie, Mildner Alexander, Eiffert Helmut, Hanisch Uwe-Karsten, Hammerschmidt Sven, Nau Roland
Department of Neurology, University of Göttingen, Robert Koch Str. 40, D-37075 Göttingen, Germany.
Infect Immun. 2009 Jan;77(1):557-64. doi: 10.1128/IAI.00903-08. Epub 2008 Nov 3.
Meningitis and meningoencephalitis caused by Escherichia coli are associated with high rates of mortality. When an infection occurs, Toll-like receptors (TLRs) expressed by microglial cells can recognize pathogen-associated molecular patterns and activate multiple steps in the inflammatory response that coordinate the brain's local defense, such as phagocytosis of invading pathogens. An upregulation of the phagocytic ability of reactive microglia could improve the host defense in immunocompromised patients against pathogens such as E. coli. Here, murine microglial cultures were stimulated with the TLR agonists Pam(3)CSK(4) (TLR1/TLR2), lipopolysaccharide (TLR4), and CpG oligodeoxynucleotide (TLR9) for 24 h. Upon stimulation, levels of tumor necrosis factor alpha and the neutrophil chemoattractant CXCL1 were increased, indicating microglial activation. Phagocytic activity was studied after adding either E. coli DH5alpha or E. coli K1 strains. After 60 and 90 min of bacterial exposure, the number of ingested bacteria was significantly higher in cells prestimulated with TLR agonists than in unstimulated controls (P < 0.01). Addition of cytochalasin D, an inhibitor of actin polymerization, blocked >90% of phagocytosis. We also analyzed the ability of microglia to kill the ingested E. coli strains. Intracellularly surviving bacteria were quantified at different time points (90, 150, 240, and 360 min) after 90 min of phagocytosis. The number of bacteria killed intracellularly after 6 h was higher in cells primed with the different TLR agonists than in unstimulated microglia. Our data suggest that microglial stimulation by the TLR system can increase bacterial phagocytosis and killing. This approach could improve central nervous system resistance to infections in immunocompromised patients.
由大肠杆菌引起的脑膜炎和脑膜脑炎与高死亡率相关。感染发生时,小胶质细胞表达的Toll样受体(TLR)可识别病原体相关分子模式,并激活炎症反应中的多个步骤,从而协调大脑的局部防御,如吞噬入侵病原体。反应性小胶质细胞吞噬能力的上调可增强免疫功能低下患者抵御大肠杆菌等病原体的宿主防御能力。在此,用TLR激动剂Pam(3)CSK(4)(TLR1/TLR2)、脂多糖(TLR4)和CpG寡脱氧核苷酸(TLR9)刺激小鼠小胶质细胞培养物24小时。刺激后,肿瘤坏死因子α和中性粒细胞趋化因子CXCL1水平升高,表明小胶质细胞被激活。添加大肠杆菌DH5α或大肠杆菌K1菌株后研究吞噬活性。细菌暴露60分钟和90分钟后,用TLR激动剂预刺激的细胞中摄入的细菌数量显著高于未刺激的对照细胞(P < 0.01)。添加肌动蛋白聚合抑制剂细胞松弛素D可阻断>90%的吞噬作用。我们还分析了小胶质细胞杀死摄入的大肠杆菌菌株的能力。吞噬90分钟后,在不同时间点(90、150、240和360分钟)对细胞内存活的细菌进行定量。用不同TLR激动剂预处理的细胞在6小时后细胞内杀死的细菌数量高于未刺激的小胶质细胞。我们的数据表明,TLR系统刺激小胶质细胞可增加细菌吞噬和杀伤。这种方法可提高免疫功能低下患者中枢神经系统对感染的抵抗力。